FDAFDA · Food and drugs·Recall number D-0087-2023
Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
Published December 28, 2022 · Recall initiated: December 16, 2022
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated
Recall details
- Brand
- GLYCOPYRROLATE
- Manufacturer
- Aurolife Pharma, LLC
- Distributor
- Nationwide in the USA and Puerto Rico.
- UPC
- 0313107014017
- Lot
- Lots: 01422002A1, Expiry: 12/2023; 01421078A3, Expiry: 09/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.